3,7-dimethyl-1-propargylxanthine has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fochtmann, L; Francis, A | 1 |
| Klitgaard, H; Knutsen, LJ; Thomsen, C | 1 |
2 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and Seizures
| Article | Year |
|---|---|
Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Electroshock; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Seizures; Theobromine; Time Factors | 1995 |
Contrasting effects of adenosine A1 and A2 receptor ligands in different chemoconvulsive rodent models.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Glutamates; Glutamic Acid; Male; Mice; Mice, Inbred Strains; Purinergic P1 Receptor Antagonists; Receptors, GABA-A; Receptors, Purinergic P1; Seizures; Theobromine; Xanthines | 1993 |